Global Biosimilars Sales Market Report 2021

1 Biosimilars Market Overview
1.1 Biosimilars Product Scope
1.2 Biosimilars Segment by Type
1.2.1 Global Biosimilars Sales by Type (2016 & 2021 & 2027)
1.2.2 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
1.2.3 Recombinant Glycosylated Proteins
1.3 Biosimilars Segment by Application
1.3.1 Global Biosimilars Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Oncology
1.3.3 Blood Disorders
1.3.4 Growth Hormonal Deficiency
1.3.5 Chronic and Autoimmune Disorders
1.3.6 Others
1.4 Biosimilars Market Estimates and Forecasts (2016-2027)
1.4.1 Global Biosimilars Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Biosimilars Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Biosimilars Price Trends (2016-2027)

2 Biosimilars Estimates and Forecasts by Region
2.1 Global Biosimilars Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Biosimilars Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Biosimilars Sales Market Share by Region (2016-2021)
2.2.2 Global Biosimilars Revenue Market Share by Region (2016-2021)
2.3 Global Biosimilars Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Biosimilars Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Biosimilars Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Biosimilars Estimates and Projections (2016-2027)
2.4.2 Europe Biosimilars Estimates and Projections (2016-2027)
2.4.3 China Biosimilars Estimates and Projections (2016-2027)
2.4.4 Japan Biosimilars Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Biosimilars Estimates and Projections (2016-2027)
2.4.6 India Biosimilars Estimates and Projections (2016-2027)

3 Global Biosimilars Competition Landscape by Players
3.1 Global Top Biosimilars Players by Sales (2016-2021)
3.2 Global Top Biosimilars Players by Revenue (2016-2021)
3.3 Global Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biosimilars as of 2020)
3.4 Global Biosimilars Average Price by Company (2016-2021)
3.5 Manufacturers Biosimilars Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Biosimilars Market Size by Type
4.1 Global Biosimilars Historic Market Review by Type (2016-2021)
4.1.1 Global Biosimilars Sales Market Share by Type (2016-2021)
4.1.2 Global Biosimilars Revenue Market Share by Type (2016-2021)
4.1.3 Global Biosimilars Price by Type (2016-2021)
4.2 Global Biosimilars Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Biosimilars Sales Forecast by Type (2022-2027)
4.2.2 Global Biosimilars Revenue Forecast by Type (2022-2027)
4.2.3 Global Biosimilars Price Forecast by Type (2022-2027)

5 Global Biosimilars Market Size by Application
5.1 Global Biosimilars Historic Market Review by Application (2016-2021)
5.1.1 Global Biosimilars Sales Market Share by Application (2016-2021)
5.1.2 Global Biosimilars Revenue Market Share by Application (2016-2021)
5.1.3 Global Biosimilars Price by Application (2016-2021)
5.2 Global Biosimilars Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Biosimilars Sales Forecast by Application (2022-2027)
5.2.2 Global Biosimilars Revenue Forecast by Application (2022-2027)
5.2.3 Global Biosimilars Price Forecast by Application (2022-2027)

6 North America Biosimilars Market Facts & Figures
6.1 North America Biosimilars Sales by Company
6.1.1 North America Biosimilars Sales by Company (2016-2021)
6.1.2 North America Biosimilars Revenue by Company (2016-2021)
6.2 North America Biosimilars Sales Breakdown by Type
6.2.1 North America Biosimilars Sales Breakdown by Type (2016-2021)
6.2.2 North America Biosimilars Sales Breakdown by Type (2022-2027)
6.3 North America Biosimilars Sales Breakdown by Application
6.3.1 North America Biosimilars Sales Breakdown by Application (2016-2021)
6.3.2 North America Biosimilars Sales Breakdown by Application (2022-2027)

7 Europe Biosimilars Market Facts & Figures
7.1 Europe Biosimilars Sales by Company
7.1.1 Europe Biosimilars Sales by Company (2016-2021)
7.1.2 Europe Biosimilars Revenue by Company (2016-2021)
7.2 Europe Biosimilars Sales Breakdown by Type
7.2.1 Europe Biosimilars Sales Breakdown by Type (2016-2021)
7.2.2 Europe Biosimilars Sales Breakdown by Type (2022-2027)
7.3 Europe Biosimilars Sales Breakdown by Application
7.3.1 Europe 148 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 148 Sales Breakdown by Application (2022-2027)

8 China Biosimilars Market Facts & Figures
8.1 China Biosimilars Sales by Company
8.1.1 China Biosimilars Sales by Company (2016-2021)
8.1.2 China Biosimilars Revenue by Company (2016-2021)
8.2 China Biosimilars Sales Breakdown by Type
8.2.1 China Biosimilars Sales Breakdown by Type (2016-2021)
8.2.2 China Biosimilars Sales Breakdown by Type (2022-2027)
8.3 China Biosimilars Sales Breakdown by Application
8.3.1 China 174 Sales Breakdown by Application (2016-2021)
8.3.2 China 174 Sales Breakdown by Application (2022-2027)

9 Japan Biosimilars Market Facts & Figures
9.1 Japan Biosimilars Sales by Company
9.1.1 Japan Biosimilars Sales by Company (2016-2021)
9.1.2 Japan Biosimilars Revenue by Company (2016-2021)
9.2 Japan Biosimilars Sales Breakdown by Type
9.2.1 Japan Biosimilars Sales Breakdown by Type (2016-2021)
9.2.2 Japan Biosimilars Sales Breakdown by Type (2022-2027)
9.3 Japan Biosimilars Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Biosimilars Market Facts & Figures
10.1 Southeast Asia Biosimilars Sales by Company
10.1.1 Southeast Asia Biosimilars Sales by Company (2016-2021)
10.1.2 Southeast Asia Biosimilars Revenue by Company (2016-2021)
10.2 Southeast Asia Biosimilars Sales Breakdown by Type
10.2.1 Southeast Asia Biosimilars Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Biosimilars Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Biosimilars Sales Breakdown by Application
10.3.1 Southeast Asia K MT Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K MT Sales Breakdown by Application (2022-2027)

11 India Biosimilars Market Facts & Figures
11.1 India Biosimilars Sales by Company
11.1.1 India Biosimilars Sales by Company (2016-2021)
11.1.2 India Biosimilars Revenue by Company (2016-2021)
11.2 India Biosimilars Sales Breakdown by Type
11.2.1 India Biosimilars Sales Breakdown by Type (2016-2021)
11.2.2 India Biosimilars Sales Breakdown by Type (2022-2027)
11.3 India Biosimilars Sales Breakdown by Application
11.3.1 India Biosimilars Sales Breakdown by Application (2016-2021)
11.3.2 India Biosimilars Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Biosimilars Business
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Business Overview
12.1.3 Pfizer Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Pfizer Biosimilars Products Offered
12.1.5 Pfizer Recent Development
12.2 Novartis
12.2.1 Novartis Corporation Information
12.2.2 Novartis Business Overview
12.2.3 Novartis Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Novartis Biosimilars Products Offered
12.2.5 Novartis Recent Development
12.3 Biocon
12.3.1 Biocon Corporation Information
12.3.2 Biocon Business Overview
12.3.3 Biocon Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Biocon Biosimilars Products Offered
12.3.5 Biocon Recent Development
12.4 Biogen
12.4.1 Biogen Corporation Information
12.4.2 Biogen Business Overview
12.4.3 Biogen Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Biogen Biosimilars Products Offered
12.4.5 Biogen Recent Development
12.5 Fresenius Kabi AG
12.5.1 Fresenius Kabi AG Corporation Information
12.5.2 Fresenius Kabi AG Business Overview
12.5.3 Fresenius Kabi AG Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Fresenius Kabi AG Biosimilars Products Offered
12.5.5 Fresenius Kabi AG Recent Development
12.6 Boehringer Ingelheim
12.6.1 Boehringer Ingelheim Corporation Information
12.6.2 Boehringer Ingelheim Business Overview
12.6.3 Boehringer Ingelheim Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Boehringer Ingelheim Biosimilars Products Offered
12.6.5 Boehringer Ingelheim Recent Development
12.7 Merck KgaA
12.7.1 Merck KgaA Corporation Information
12.7.2 Merck KgaA Business Overview
12.7.3 Merck KgaA Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Merck KgaA Biosimilars Products Offered
12.7.5 Merck KgaA Recent Development
12.8 Mylan
12.8.1 Mylan Corporation Information
12.8.2 Mylan Business Overview
12.8.3 Mylan Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Mylan Biosimilars Products Offered
12.8.5 Mylan Recent Development
12.9 Eli Lilly
12.9.1 Eli Lilly Corporation Information
12.9.2 Eli Lilly Business Overview
12.9.3 Eli Lilly Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Eli Lilly Biosimilars Products Offered
12.9.5 Eli Lilly Recent Development
12.10 Teva Pharmaceutical
12.10.1 Teva Pharmaceutical Corporation Information
12.10.2 Teva Pharmaceutical Business Overview
12.10.3 Teva Pharmaceutical Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Teva Pharmaceutical Biosimilars Products Offered
12.10.5 Teva Pharmaceutical Recent Development
12.11 Dr. Reddy's Laboratories
12.11.1 Dr. Reddy's Laboratories Corporation Information
12.11.2 Dr. Reddy's Laboratories Business Overview
12.11.3 Dr. Reddy's Laboratories Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Dr. Reddy's Laboratories Biosimilars Products Offered
12.11.5 Dr. Reddy's Laboratories Recent Development
12.12 Amgen
12.12.1 Amgen Corporation Information
12.12.2 Amgen Business Overview
12.12.3 Amgen Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Amgen Biosimilars Products Offered
12.12.5 Amgen Recent Development
12.13 Celltrion
12.13.1 Celltrion Corporation Information
12.13.2 Celltrion Business Overview
12.13.3 Celltrion Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Celltrion Biosimilars Products Offered
12.13.5 Celltrion Recent Development
12.14 Samsung Biologics
12.14.1 Samsung Biologics Corporation Information
12.14.2 Samsung Biologics Business Overview
12.14.3 Samsung Biologics Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Samsung Biologics Biosimilars Products Offered
12.14.5 Samsung Biologics Recent Development
12.15 Roche
12.15.1 Roche Corporation Information
12.15.2 Roche Business Overview
12.15.3 Roche Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Roche Biosimilars Products Offered
12.15.5 Roche Recent Development
12.16 Probiomed
12.16.1 Probiomed Corporation Information
12.16.2 Probiomed Business Overview
12.16.3 Probiomed Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Probiomed Biosimilars Products Offered
12.16.5 Probiomed Recent Development
12.17 Apotex
12.17.1 Apotex Corporation Information
12.17.2 Apotex Business Overview
12.17.3 Apotex Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Apotex Biosimilars Products Offered
12.17.5 Apotex Recent Development
12.18 Chong Kun Dang
12.18.1 Chong Kun Dang Corporation Information
12.18.2 Chong Kun Dang Business Overview
12.18.3 Chong Kun Dang Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Chong Kun Dang Biosimilars Products Offered
12.18.5 Chong Kun Dang Recent Development
12.19 JCR Pharmaceuticals
12.19.1 JCR Pharmaceuticals Corporation Information
12.19.2 JCR Pharmaceuticals Business Overview
12.19.3 JCR Pharmaceuticals Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.19.4 JCR Pharmaceuticals Biosimilars Products Offered
12.19.5 JCR Pharmaceuticals Recent Development
12.20 Gan & Lee Pharmaceuticals
12.20.1 Gan & Lee Pharmaceuticals Corporation Information
12.20.2 Gan & Lee Pharmaceuticals Business Overview
12.20.3 Gan & Lee Pharmaceuticals Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Gan & Lee Pharmaceuticals Biosimilars Products Offered
12.20.5 Gan & Lee Pharmaceuticals Recent Development
12.21 Gedeon Richter
12.21.1 Gedeon Richter Corporation Information
12.21.2 Gedeon Richter Business Overview
12.21.3 Gedeon Richter Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.21.4 Gedeon Richter Biosimilars Products Offered
12.21.5 Gedeon Richter Recent Development
12.22 Biocad
12.22.1 Biocad Corporation Information
12.22.2 Biocad Business Overview
12.22.3 Biocad Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.22.4 Biocad Biosimilars Products Offered
12.22.5 Biocad Recent Development
12.23 Coherus Bioscience
12.23.1 Coherus Bioscience Corporation Information
12.23.2 Coherus Bioscience Business Overview
12.23.3 Coherus Bioscience Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.23.4 Coherus Bioscience Biosimilars Products Offered
12.23.5 Coherus Bioscience Recent Development
12.24 Stada Arzneimittel AG
12.24.1 Stada Arzneimittel AG Corporation Information
12.24.2 Stada Arzneimittel AG Business Overview
12.24.3 Stada Arzneimittel AG Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.24.4 Stada Arzneimittel AG Biosimilars Products Offered
12.24.5 Stada Arzneimittel AG Recent Development

13 Biosimilars Manufacturing Cost Analysis
13.1 Biosimilars Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Biosimilars
13.4 Biosimilars Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Biosimilars Distributors List
14.3 Biosimilars Customers

15 Market Dynamics
15.1 Biosimilars Market Trends
15.2 Biosimilars Drivers
15.3 Biosimilars Market Challenges
15.4 Biosimilars Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

no record found